Strong Multi-year Revenue GrowthConsistent multi-year top-line growth, with acceleration in 2025 and continuation in 2026, increases operating scale and market penetration. Durable revenue expansion supports purchasing leverage, store/pharmacy investment and underpins more reliable long-term cash flow generation.
Improved Cash Generation In 2026A meaningful rebound in operating and free cash flow in 2026 materially improves internal funding capacity. Stronger cash generation enhances financial flexibility for capex, working capital and deleveraging, reducing near-term dependence on external financing for strategic initiatives.
Resilient Retail + Pharmacy Business ModelThe combined retail and prescription-dispensing model creates recurring revenue from pharmacy fees plus diversified merchandise sales. This vertical mix drives steady store traffic, cross-sell potential and predictable billing streams, supporting durable demand and repeat customer flows.